SeaStar Medical Holding Corporation
ICU
Rank in Stocks
#30270
SeaStar Medical Holding Corporation is a medical device company dedicated to... SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a process that directly harms tissues and releases a cascade of pro-inflammatory cytokines, thereby initiating and perpetuating dysregulated immune reactions. Its product pipeline spans various critical care areas, including acute kidney injury (both pediatric and adult) requiring continuous renal replacement therapy (CRRT), cardiorenal syndrome in patients with congestive heart failure (including those with or without LVADs), myocardial stunning in end-stage renal disease, and hepatorenal syndrome. The firm maintains its headquarters in Denver, Colorado.
Share Price
$1.96
Last synced: 2026-11-09
Market Cap
$5.56M
Change (1 day)
4.26%
Change (1 year)
-60.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SeaStar Medical Holding Corporation (ICU)
Category
Healthcare
EPS for SeaStar Medical Holding Corporation (ICU)
EPS as of June 2026 TTM: $-3.91
According to SeaStar Medical Holding Corporation's latest financial reports, its current EPS (TTM) is $-3.91. At the end of 2025 the company had an EPS of $-5.86, an increase over its 2024 EPS of $-66.30.
EPS history for SeaStar Medical Holding Corporation from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-3.91 | -33.28% |
| 2025 | $-5.86 | -91.16% |
| 2024 | $-66.30 | -78.09% |
| 2023 | $-302.62 | 29.44% |
| 2022 | $-233.80 | 165.38% |
| 2021 | $-88.10 | 88,000.00% |
| 2020 | $-0.10 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -500.51% |
US
|
|
| $-7.07 | 80.82% |
US
|
|
| $-5.29 | 35.29% |
AU
|
|
| $12.88 | -429.41% |
BE
|
|
| $21.56 | -651.41% |
NL
|
Questions about SeaStar Medical Holding Corporation's earnings per share (EPS)
What is SeaStar Medical Holding Corporation's earnings per share (EPS)?
SeaStar Medical Holding Corporation's earnings per share (EPS) over the last twelve months is $-3.91, as of Jun 2026.
What was SeaStar Medical Holding Corporation's earnings per share (EPS) in 2025?
In 2025, SeaStar Medical Holding Corporation's earnings per share (EPS) was $-5.86, compared with $-66.30 in 2024.
How has SeaStar Medical Holding Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, SeaStar Medical Holding Corporation's earnings per share (EPS) was highest in 2020 ($-0.10) and lowest in 2023 ($-302.62).
How does SeaStar Medical Holding Corporation's earnings per share (EPS) compare with similar companies?
SeaStar Medical Holding Corporation's earnings per share (EPS) ($-3.91) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.